These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 22805248)

  • 1. MCT8 deficiency: extrapyramidal symptoms and delayed myelination as prominent features.
    Tonduti D; Vanderver A; Berardinelli A; Schmidt JL; Collins CD; Novara F; Genni AD; Mita A; Triulzi F; Brunstrom-Hernandez JE; Zuffardi O; Balottin U; Orcesi S
    J Child Neurol; 2013 Jun; 28(6):795-800. PubMed ID: 22805248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MCT8 mutation analysis and identification of the first female with Allan-Herndon-Dudley syndrome due to loss of MCT8 expression.
    Frints SG; Lenzner S; Bauters M; Jensen LR; Van Esch H; des Portes V; Moog U; Macville MV; van Roozendaal K; Schrander-Stumpel CT; Tzschach A; Marynen P; Fryns JP; Hamel B; van Bokhoven H; Chelly J; Beldjord C; Turner G; Gecz J; Moraine C; Raynaud M; Ropers HH; Froyen G; Kuss AW
    Eur J Hum Genet; 2008 Sep; 16(9):1029-37. PubMed ID: 18398436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monocarboxylate Transporter 8 Deficiency: Delayed or Permanent Hypomyelination?
    Vancamp P; Demeneix BA; Remaud S
    Front Endocrinol (Lausanne); 2020; 11():283. PubMed ID: 32477268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. X-linked MCT8 gene mutations: characterization of the pediatric neurologic phenotype.
    Holden KR; Zuñiga OF; May MM; Su H; Molinero MR; Rogers RC; Schwartz CE
    J Child Neurol; 2005 Oct; 20(10):852-7. PubMed ID: 16417886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1H magnetic resonance spectroscopy in monocarboxylate transporter 8 gene deficiency.
    Sijens PE; Rödiger LA; Meiners LC; Lunsing RJ
    J Clin Endocrinol Metab; 2008 May; 93(5):1854-9. PubMed ID: 18319316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe neurological abnormalities in a young boy with impaired thyroid hormone sensitivity due to a novel mutation in the MCT8 gene.
    Rego T; Lado CG; Rodríguez PC; Santos FS; Angueira FB; Castro-Feijóo L; Conde JB; Castro-Gago M
    Hormones (Athens); 2017 Apr; 16(2):194-199. PubMed ID: 28742507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aicardi-Goutières syndrome: special type early-onset encephalopathy.
    Aicardi J
    Eur J Paediatr Neurol; 2002; 6 Suppl A():A1-7; discussion A23-5, A77-86. PubMed ID: 12365357
    [No Abstract]   [Full Text] [Related]  

  • 8. Psychomotor retardation caused by a defective thyroid hormone transporter: report of two families with different MCT8 mutations.
    Anık A; Kersseboom S; Demir K; Catlı G; Yiş U; Böber E; van Mullem A; van Herebeek RE; Hız S; Abacı A; Visser TJ
    Horm Res Paediatr; 2014; 82(4):261-71. PubMed ID: 25247785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allan-Herndon-Dudley syndrome and the monocarboxylate transporter 8 (MCT8) gene.
    Schwartz CE; May MM; Carpenter NJ; Rogers RC; Martin J; Bialer MG; Ward J; Sanabria J; Marsa S; Lewis JA; Echeverri R; Lubs HA; Voeller K; Simensen RJ; Stevenson RE
    Am J Hum Genet; 2005 Jul; 77(1):41-53. PubMed ID: 15889350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations of the thyroid hormone transporter MCT8 cause prenatal brain damage and persistent hypomyelination.
    López-Espíndola D; Morales-Bastos C; Grijota-Martínez C; Liao XH; Lev D; Sugo E; Verge CF; Refetoff S; Bernal J; Guadaño-Ferraz A
    J Clin Endocrinol Metab; 2014 Dec; 99(12):E2799-804. PubMed ID: 25222753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypomyelination with atrophy of the basal ganglia and cerebellum: follow-up and pathology.
    van der Knaap MS; Linnankivi T; Paetau A; Feigenbaum A; Wakusawa K; Haginoya K; Köhler W; Henneke M; Dinopoulos A; Grattan-Smith P; Brockmann K; Schiffmann R; Blaser S
    Neurology; 2007 Jul; 69(2):166-71. PubMed ID: 17620549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disease characteristics of MCT8 deficiency: an international, retrospective, multicentre cohort study.
    Groeneweg S; van Geest FS; Abacı A; Alcantud A; Ambegaonkar GP; Armour CM; Bakhtiani P; Barca D; Bertini ES; van Beynum IM; Brunetti-Pierri N; Bugiani M; Cappa M; Cappuccio G; Castellotti B; Castiglioni C; Chatterjee K; de Coo IFM; Coutant R; Craiu D; Crock P; DeGoede C; Demir K; Dica A; Dimitri P; Dolcetta-Capuzzo A; Dremmen MHG; Dubey R; Enderli A; Fairchild J; Gallichan J; George B; Gevers EF; Hackenberg A; Halász Z; Heinrich B; Huynh T; Kłosowska A; van der Knaap MS; van der Knoop MM; Konrad D; Koolen DA; Krude H; Lawson-Yuen A; Lebl J; Linder-Lucht M; Lorea CF; Lourenço CM; Lunsing RJ; Lyons G; Malikova J; Mancilla EE; McGowan A; Mericq V; Lora FM; Moran C; Müller KE; Oliver-Petit I; Paone L; Paul PG; Polak M; Porta F; Poswar FO; Reinauer C; Rozenkova K; Menevse TS; Simm P; Simon A; Singh Y; Spada M; van der Spek J; Stals MAM; Stoupa A; Subramanian GM; Tonduti D; Turan S; den Uil CA; Vanderniet J; van der Walt A; Wémeau JL; Wierzba J; de Wit MY; Wolf NI; Wurm M; Zibordi F; Zung A; Zwaveling-Soonawala N; Visser WE
    Lancet Diabetes Endocrinol; 2020 Jul; 8(7):594-605. PubMed ID: 32559475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical phenotype and endocrinological investigations in a patient with a mutation in the MCT8 thyroid hormone transporter.
    Namba N; Etani Y; Kitaoka T; Nakamoto Y; Nakacho M; Bessho K; Miyoshi Y; Mushiake S; Mohri I; Arai H; Taniike M; Ozono K
    Eur J Pediatr; 2008 Jul; 167(7):785-91. PubMed ID: 17899191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overcoming Monocarboxylate Transporter 8 (MCT8)-Deficiency to Promote Human Oligodendrocyte Differentiation and Myelination.
    Lee JY; Kim MJ; Deliyanti D; Azari MF; Rossello F; Costin A; Ramm G; Stanley EG; Elefanty AG; Wilkinson-Berka JL; Petratos S
    EBioMedicine; 2017 Nov; 25():122-135. PubMed ID: 29111262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diiodothyropropionic acid (DITPA) in the treatment of MCT8 deficiency.
    Verge CF; Konrad D; Cohen M; Di Cosmo C; Dumitrescu AM; Marcinkowski T; Hameed S; Hamilton J; Weiss RE; Refetoff S
    J Clin Endocrinol Metab; 2012 Dec; 97(12):4515-23. PubMed ID: 22993035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. White matter abnormalities and dystonic motor disorder associated with mutations in the SLC16A2 gene.
    Gika AD; Siddiqui A; Hulse AJ; Edward S; Fallon P; McEntagart ME; Jan W; Josifova D; Lerman-Sagie T; Drummond J; Thompson E; Refetoff S; Bönnemann CG; Jungbluth H
    Dev Med Child Neurol; 2010 May; 52(5):475-82. PubMed ID: 19811520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [MCT8-specific thyroid hormone cell transporter deficiency: a case report and review of the literature].
    López-Marín L; Martín-Belinchón M; Gutiérrez-Solana LG; Morte-Molina B; Duat-Rodríguez A; Bernal J
    Rev Neurol; 2013 Jun; 56(12):615-22. PubMed ID: 23744248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel monocarboxylate transporter 8 gene mutation as a cause of severe neonatal hypotonia and developmental delay.
    Papadimitriou A; Dumitrescu AM; Papavasiliou A; Fretzayas A; Nicolaidou P; Refetoff S
    Pediatrics; 2008 Jan; 121(1):e199-202. PubMed ID: 18166539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel mutations in SLC16A2 associated with a less severe phenotype of MCT8 deficiency.
    Masnada S; Groenweg S; Saletti V; Chiapparini L; Castellotti B; Salsano E; Visser WE; Tonduti D
    Metab Brain Dis; 2019 Dec; 34(6):1565-1575. PubMed ID: 31332729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonprogressive familial leukoencephalopathy with porencephalic cyst and focal seizures.
    Blumkin L; Watemberg N; Lev D; Malinger G; Luckman Y; Ben-Zeev B; Lerman-Sagie T
    J Child Neurol; 2006 Feb; 21(2):145-8. PubMed ID: 16566879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.